Early intervention, which can be achieved through laser photocoagulation therapy or intravitreal administration of anti-vascular endothelial growth factor (anti-VEGF) agents, serves as a critical preventative measure against the progression of ROP (3). This evidence concerns the gene VEGFA and retinopathy of prematurity.